As the Centers for Medicare and Medicaid Services (CMS) prepare to implement the Inflation Reduction Act’s price controls for prescription drugs, the agency has been hit with lawsuits from both Merck and the U.S. Chamber of Commerce alleging violation of their constitutional rights. While we cannot know whether these challenges will prevail, the effects of this law on patients are easily predictable: higher launch prices, fewer cures and worse health.
Merck’s lawsuit centers o...
Biden’s drug price controls are disastrous — are they also unconstitutional?
As the Centers for Medicare and Medicaid Services (CMS) prepare to implement the Inflation Reduction Act’s price controls for prescription drugs, the agency has been hit with lawsuits from both Merck and the U.S. Chamber of Commerce alleging violation of their constitutional rights. While we cannot know whether these challenges will prevail, the effects of this law on patients are easily predictable: higher launch prices, fewer cures and worse health.
Merck’s lawsuit centers o...